Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2015 Aug;8(8):720-8.
doi: 10.1158/1940-6207.CAPR-14-0407. Epub 2015 Jun 1.

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin

Affiliations
Randomized Controlled Trial

Activation of the PI3K/Akt/mTOR and MAPK Signaling Pathways in Response to Acute Solar-Simulated Light Exposure of Human Skin

Yira Bermudez et al. Cancer Prev Res (Phila). 2015 Aug.

Abstract

The incidence of skin cancer is higher than all other cancers and continues to increase, with an average annual cost over $8 billion in the United States. As a result, identifying molecular pathway alterations that occur with UV exposure to strategize more effective preventive and therapeutic approaches is essential. To that end, we evaluated phosphorylation of proteins within the PI3K/Akt and MAPK pathways by immunohistochemistry in sun-protected skin after acute doses of physiologically relevant solar-simulated ultraviolet light (SSL) in 24 volunteers. Biopsies were performed at baseline, 5 minutes, 1, 5, and 24 hours after SSL irradiation. Within the PI3K/Akt pathway, we found activation of Akt (serine 473) to be significantly increased at 5 hours while mTOR (serine 2448) was strongly activated early and was sustained over 24 hours after SSL. Downstream, we observed a marked and sustained increase in phospho-S6 (serine 235/S236), whereas phospho-4E-BP1 (threonines 37/46) was increased only at 24 hours. Within the MAPK pathway, SSL-induced expression of phospho-p38 (threonine 180/tyrosine 182) peaked at 1 to 5 hours. ERK 1/2 was observed to be immediate and sustained after SSL irradiation. Phosphorylation of histone H3 (serine 10), a core structural protein of the nucleosome, peaked at 5 hours after SSL irradiation. The expression of both p53 and COX-2 was increased at 5 hours and was maximal at 24 hours after SSL irradiation. Apoptosis was significantly increased at 24 hours as expected and indicative of a sunburn-type response to SSL. Understanding the timing of key protein expression changes in response to SSL will aid in development of mechanistic-based approaches for the prevention and control of skin cancers.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Examples of immunohistochemically stained proteins in sun-protected skin after 2–3 MED of SSL-irradiation. Phospho-Akt (Serine 473), at baseline (a), 1 hour (b), 5 hours (c), and 24 hours (d). Phospho-mTOR (Serine 2448) expression at baseline (e), 1 hour (f), 5 hours (g), and 24 hours (h). Images are at a magnification of 400X and the scale bar represents 50 μm. Red nuclear and cytoplasmic staining is positive and blue is negative.
Figure 2
Figure 2
Examples of immunohistochemically stained proteins in sun-protected skin after 2–3 MED of SSL-irradiation. Phospho-S6 (Serines 235/236) expression at baseline (a), 1 hour (b), 5 hours (c), and 24 hours (d). Phospho-4E-BP1 (Threonines 37/46) expression at baseline (e), 1 hour (f), 5 hours (g), and 24 hours (h). Images are at a magnification of 400X and the scale bar represents 50 μm. Red nuclear and cytoplasmic staining is positive and blue is negative.
Figure 3
Figure 3
Examples of immunohistochemically stained proteins in sun-protected skin after 2–3 MED of SSL-irradiation. Phospho-p38 (Threonine 180/Tyrosine 182) expression at baseline (a), 1 hour (b), 5 hours (c), and 24 hours (d). Phospho-ERK 1/2 (Threonine 202/Tyrosine 204) expression at baseline (e), 1 hour (f), 5 hours (g), and 24 hours (h). Phospho-histone H3 (Serine 10) expression at baseline (i), 1 hour (j), 5 hours (k), and 24 hours (l). Images are at a magnification of 400X and the scale bar represents 50 μm. Red (phospho-ERK 1/2 and phospho-histone H3) or brown (phospho-p38) nuclear and cytoplasmic stains represent positive and blue stain represents negative staining.
Figure 4
Figure 4
Examples of immunohistochemically stained proteins in sun-protected skin after 2–3 MED of SSL-irradiation. COX-2 expression at baseline (a), 1 hour (b), 5 hours (c), and 24 hours (d). p53 expression at baseline (e), 1 hour (f), 5 hours (g), and 24 hours (h). Images are at a magnification of 400X and the scale bar represents 50 μm. Brown nuclear and cytoplasmic stains represent positive and blue stain represents negative staining.
Figure 5
Figure 5
Examples of proliferation and apoptosis in sun-protected skin after 2–3 MED of SSL-irradiation. PCNA expression at baseline (a), 1 hour (b), 5 hours (c), and 24 hours (d) post SSL. Cleaved caspase 3 at baseline (a) and 24 hours (b). Apoptotic cells on H&E stained slides at baseline (c) and at 24 hours with inset in the lower left at a magnification of 1000X (d). Images of are at a magnification of 400X the scale bar represents 50 μm. Brown nuclear stain is positive for PCNA (a–d). Red stain is positive and blue is negative for cleaved caspase 3 (e and f). Arrows point to apoptotic cells present at 24 hours post SSL.

References

    1. Rogers HW, Weinstock MA, Harris AR, Hinckley MR, Feldman SR, Fleischer AB, et al. Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol. 2010;146:283–7. - PubMed
    1. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985–1996. Journal of the American Academy of Dermatology. 2001;45:528–36. - PubMed
    1. Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg. 2001;27:955–9. - PubMed
    1. Guy GP, Jr, Machlin SR, Ekwueme DU, Yabroff KR. Prevalence and costs of skin cancer treatment in the U.S., 2002–2006 and 2007–2011. American journal of preventive medicine. 2015;48:183–7. - PMC - PubMed
    1. Gasparro FP. Sunscreens, skin photobiology, and skin cancer: The need for UVA protection and evaluation of efficacy. Environ Health Persp. 2000;108:71–78. - PMC - PubMed

Publication types

MeSH terms

Substances